MyJournals Home  

RSS FeedsMolecules, Vol. 28, Pages 1217: PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities (Molecules)


26 january 2023 15:14:09

Molecules, Vol. 28, Pages 1217: PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities (Molecules)

The epigenetic regulation of gene functions has been proven to be strongly associated with the development and progression of cancer. Reprogramming the cancer epigenome landscape is one of the most promising target therapies in both treatments and in reversing drug resistance. Proteolytic targeted chimeras (PROTACs) are an emerging therapeutic modality for selective degradation via the native ubiquitin-proteasome system. Rapid advances in PROTACs have facilitated the exploration of targeting epigenetic proteins, yielding effective strategies to target transcription while reducing toxicities to untransformed cells. A lot of PROTAC degraders have already been designed in the field of epigenetic cancer therapy, and PROTACs targeting epigenetic proteins can better exploit target druggability and improve the mechanistic understanding of the epigenetic regulation of cancer. Thus, this review focuses on the progress made in the development of PROTAC degraders and PROTAC drugs targeting epigenetics in cancer and discusses challenges and future opportunities for the field.

60 viewsCategory: Biochemistry, Chemistry, Molecular Biology
Molecules, Vol. 28, Pages 1216: Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy (Molecules)
Molecules, Vol. 28, Pages 1218: BiVO4–Deposited MIL–101–NH2 for Efficient Photocatalytic Elimination of Cr(VI) (Molecules)
blog comments powered by Disqus
The latest issues of all your favorite science journals on one page


Register | Retrieve


Molecular Biology

Copyright © 2008 - 2023 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten